Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso

Clinical Infectious Diseases

Volumn 43, Issue 6, 2006, Pages 693-700

  Yaro, Seydou ^a   Lourd, Mathilde ^e   Traoré, Yves ^c   Njanpop Lafourcade, Berthe Marie ^e   Sawadogo, Adrien ^b   Sangare, Lassana ^d   Hien, Alain ^b   Ouedraogo, Macaire S ^e   Sanou, Oumarou ^e   Parent Du Châtelet, Isabelle ^e   Koeck, Jean Louis ^f   Gessner, Bradford D ^e,g  

^a CENTRE MURAZ   (Burkina Faso)

^b Centre Hospitalier National Souro Sanou   (Burkina Faso)

^c UNIVERSITÉ DE OUAGADOUGOU   (Burkina Faso)

^d CENTRE HOSPITALIER UNIVERSITAIRE YALGADO OUÉDRAOGO   (Burkina Faso)

^e Agence de Medecine Preventive   (France)

^f HÔPITAL D'INSTRUCTION DES ARMÉES ROBERT PICQUÉ   (France)

^g INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEFTRIAXONE; CHLORAMPHENICOL; ERYTHROMYCIN; OXACILLIN; PENICILLIN G; SULFAMETHOXAZOLE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ARTICLE; BACTERIAL INFECTION; BACTERIAL MENINGITIS; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BURKINA FASO; CEREBROSPINAL FLUID CULTURE; CHILD; EPIDEMIC; HUMAN; INFANT; LABORATORY DIAGNOSIS; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEASONAL VARIATION; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BURKINA FASO; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; INFANT; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PHYLOGENY; SEASONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 33748286755     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/506940     Document Type: Article

References (33)

1. Nicolas P, Raphenon G, Guibourdenche M, Decousset L, Stor R, Gaye AB. The 1998 Senegal epidemic of meningitis was due to the clonal expansion of A:4:P1.9, clone III-1, sequence type 5 Neisseria meningitidis strains. J Clin Microbiol 2000; 38:198-200.
2. Moore PS, Reeves MW, Schwartz B, Gellin BG, Broome CV. Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet 1989; 2:260-3.
3. Decosas J, Koama JB. Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso. Lancet Infect Dis 2002; 2:763-5.
4. Parent du Châtelet I, Traoré Y, Gessner BD, et al. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin Infect Dis 2005; 40:17-25.
5. Cadoz M, Denis F, Mar ID. Etude epidemiologique des cas de meningites purulentes hospitalises a Dakar pendant la decennie 1970-1979. Bull World Health Organ 1981; 59:575-84.
6. Campagne G, Schuchat A, Djibo S, et al. Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96. Bull World Health Organ 1999; 77:499-507.
7. Leimkugel J, Adams Forgor A, Gagneux S, et al. An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis 2005; 192:192-9.
8. World Health Organization (WHO). Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. WHO/CDS/CSR/EDC/99.7. WHO Commun Dis Surveill Response 1999:1-74.
9. Hassan-King M, Baldeh I, Adegbola R, et al. Detection of Haemophius influenzae and Streptococcus pneumoniae DNA in blood culture by a single PCR assay. J Clin Microbiol 1996; 34:2030-2.
10. Comite de l'Antibiogramme de la Societe Francaise de Microbiologie report 2003. Int J Antimicrob Agents 2003; 21:364-91.
11. Slotved HC, Kaltoft M, Skovsted IC, Kerrn MB, Espersen F. Simple, rapid latex agglutination test for serotyping of pneumococcus (Pneumotest-Latex). J Clin Microbiol 2004; 42:2518-22.
12. Fabre M, Koeck JL, Le Fleche P, et al. High genetic diversity revealed by variable-number tandem repeat genotyping and analysis of hsp65 gene polymorphism in a large collection of "Mycobacterium canettii" strains indicates that the M. tuberculosis complex is a recently emerged clone of "M. canettii". J Clin Microbiol 2004; 42:3248-55.
13. Le Fleche P, Fabre M, Denoeud F, Koeck JL, Vergnaud G. High resolution, on-line identification of strains from the Mycobacterium tuberculosis complex based on tandem repeat typing. BMC Microbiol 2002; 2:37.
14. Koeck JL, Njanpop-Lafourcade BM, Cade S, et al. Evaluation and selection of tandem repeat loci for Streptococcus pneumoniae MLVA strain typing. BMC Microbiol 2005; 5:66.
15. Malachowa N, Sabat A, Gniadkowski M, et al. Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis, spa typing, and multilocus sequence typing for clonal characterization of Staphylococcus aureus isolates. J Clin Microbiol 2005; 43:3095-100.
16. Johansson A, Koskiniemi S, Gottfridsson P, Wistrom J, Monsen T. Multiple-locus variable-number tandem repeat analysis for typing of Staphylococcus epidermidis. J Clin Microbiol 2006; 44:260-5.
17. http://bacterial-genotyping.igmors.u-psud.fr/Spneumoniae/. Accessed 13 April 2006.
18. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998; 144:3049-60.
19. Multi locus sequence typing. Available at: http://spneumoniae.mlst.net. Accessed 14 August 2006.
20. Moore PS. Meningococcal meningitis in sub-Saharan Africa: a model for the epidemic process. Clin Infect Dis 1992; 14:515-25.
21. Klugman KP, Madhi SA, Huebner RE, et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003; 349:1341-8.
22. Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005; 365:1139-46.
23. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348:1737-46.
24. Gordon SB, Kanyanda S, Walsh AL, et al. Poor potential coverage for 7-valent pneumococcal conjugate vaccine, Malawi. Emerg Infect Dis 2003; 9:747-9.
25. Brueggemann AB, Spratt BG. Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J Clin Microbiol 2003; 41:4966-70.
26. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005; 54:893-7.
27. Swiatlo E, Ware D. Novel vaccine strategies with protein antigens of Streptococcus pneumoniae. FEMS Immunol Med Microbiol 2003; 38:1-7.
28. Riley ID, Lehmann D, Alpers MP. Pneumococcal vaccine trials in Papua New Guinea: relationships between epidemiology of pneumococcal infection and efficacy of vaccine. Rev Infect Dis 1991; 13(Suppl 6):S535-41.
29. Mangtani P, Cutts F, Hall AJ. Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence. Lancet Infect Dis 2003; 3:71-8.
30. Cornu C, Yzebe D, Leophonte P, Gaillat J, Boissel JP, Cucherat M. Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials. Vaccine 2001; 19:4780-90.
31. French N, Nakiyingi J, Carpenter LM, et al. 23-Valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000; 355:2106-11.
32. Lewis RF, Dorlencourt F, Pinel J. Long-acting oily chloramphenicol for meningococcal meningitis. Lancet 1998; 352:823.
33. World Health Organization. Meningococcal meningitis: fact sheet number 141. 2003. Available at: http://www.who.int/mediacentre/factsheets/2003/fs141/ en/. Accessed 15 July 2005.